Adamas Pharma Cash Flow - Annual (NASDAQ:ADMS)

Add to My Stocks
$25.5 $0.69 (2.63%) ADMS stock closing price Jun 21, 2018 (Closing)

The Adamas Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Adamas Pharma profits and Adamas Pharma debt. Adamas Pharma saw a cash impact of $9.11M from the issuance of ADMS shares. The cash flow statement helps in the Adamas Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. ADMS increase in investments stood at a value of $25.56M for the latest year 2017.

View details of Adamas Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Net Income Cash Flow
-89.49M-60.05M-51.8M10.22M50.92M17.73M
Depreciation Depletion Amortization Cash-Flow1.65M-----
Net Increase (Decrease) in Assets Liabilities3.29M--6.67M10.47M-29.4M31.45M
Cash From (used in) Discontinued Operations------
Other Adjustments Net17.71M10.57M10.83M5.33M5.21M2.72M
Net Cash from (used by) Operating Activities
-66.82M-48.06M-47.21M26.19M26.8M51.96M
Increase (Decrease) in Prop Plant And Equipment-1.25M-1.62M-1.39M-1.28M-0.16M-0.02M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments26.82M-25.08M9.45M-96.09M--
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
25.56M-26.7M8.05M-97.38M-0.16M-0.02M
Issuance (Purchase) of Equity Shares9.11M64.78M10.4M45.25M-3.95M
Issuance (Repayment) of Debt Securities99.6M-----
Increase (Decrease) in Bank & Other Borrowings-----4M3.94M
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities---1.76M--
Net Cash from (used by) Financing Activities
108.84M65.4M10.81M47.02M-3.97M7.9M
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
67.58M-9.36M-28.34M-24.16M22.65M59.84M
Cash & Equivalents at Beginning of Year23.73M33.1M61.44M85.61M62.95M3.11M
Cash & Equivalents at Year End91.31M23.73M33.1M61.44M85.61M62.95M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Adamas Pharma stock price history provides insight into historical stock price fluctuations, and Adamas Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Adamas Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Adamas Pharma stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-66.82M for ADMS.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $25.56M for ADMS in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $108.84M for Adamas Pharma.

Key Financial Ratios For Adamas Pharma Cash Flow

Annual Cash Flow Statements For Adamas Pharmaceuticals Inc Peers

Acadia Pharma cash flow, Amphastar Pharma cash flow, Cymabay cash flow, GlaxoSmithKline cash flow, Merck cash flow